X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-13-2023-38736.pdf
https://www.prnewswire.com/news-releases/redhills-rhb-102-bekinda-and-opaganib-granted-new-patents-in-oncology-setting-301811839.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf
https://www.fiercepharma.com/pharma/heron-scores-fda-go-ahead-aponvie-iv-alternative-pills-postoperative-nausea
https://athenapharmaceutiques.com/wp-content/uploads/2022/03/March-2022-Athenas-First-Market-Authorization-in-Brazil-with-Ondansetron-ODT.pdf
https://www.fiercepharma.com/pharma/glaxosmithkline-scores-a-big-win-its-zofran-litigation-after-fda-repeatedly-rejects
https://www.hikma.com/newsroom/article-i4595-civica-rx-and-hikma-announce-shipments-of-heparin-and-seven-other-essential-injectable-medicines/
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-cellchem-pharmaceuticals-ondansetron-1571635635.pdf
https://www.pharmacompass.com/pdf/news/thae-pharmacovigilance-management-warns-of-the-risk-of-congenital-malformations-with-the-use-ondansetron-anvisa-1571635156.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-14-2019-1565765849.pdf
https://globenewswire.com/news-release/2019/01/04/1680840/0/en/ChemioCare-Initiates-Development-Program-in-Pediatric-CINV.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-16-2018-1526446624.pdf
https://www.prnewswire.com/news-releases/imprimis-pharmaceuticals-to-feature-its-patent-pending-cyclosporinechondroitin-sulfate-and-patented-non-opioid-mko-melt-midazolamketamineondansetron-formulations-at-the-upcoming-cataract--refractive-surgery-medical-meeting-300626616.html
https://www.biospace.com/article/imprimis-jumps-secures-patent-for-non-opioid-compound/
https://www.pharmacompass.com/pdf/news/fresenius-kabi-issues-voluntary-nationwide-recall-of-midazolam-injection-usp-2-mg2-ml-1509770761.pdf
https://globenewswire.com/news-release/2017/02/07/914656/0/en/MonoSol-Rx-Receives-FDA-Acceptance-of-New-Drug-Application-for-Tadalafil-PharmFilm.html
https://globenewswire.com/news-release/2017/01/24/910367/0/en/MonoSol-Rx-Appoints-John-T-Maxwell-as-Chief-Financial-Officer.html
https://globenewswire.com/news-release/2017/01/13/905801/0/en/MonoSol-Rx-Files-Patent-Infringement-Suit-against-BioDelivery-Sciences-International-BDSI.html
https://globenewswire.com/news-release/2016/11/28/893090/0/en/MonoSol-Rx-Submits-New-Drug-Application-for-Tadalafil-PharmFilm.html
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lincoln-pharma-launches-ondansetron-oral-spray-in-india/articleshow/54463181.cms
http://www.pharmamanufacturing.com/industrynews/2016/teva-recalls-4-drugs-made-at-banned-plant/
https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-18may2016-1463569543.pdf
http://www.biospace.com/News/midatech-bags-galena-biopharma-s-zuplenz-in-29-75/403484/source=TopBreaking
http://www.digitaljournal.com/life/health/canadian-women-file-class-action-lawsuit-over-anti-nausea-drug/article/451638?
https://athenapharmaceutiques.com/wp-content/uploads/2020/12/November-2015-Ondansetron-ODT-1.pdf
http://www.biospectrumindia.com/biospecindia/news/220279/usfda-issues-import-alert-ipca-labs
Market Place
Share 
